GSI 150 (Viread 150 mg)
Generic Name: tenofovir
Pill imprint GSI 150 has been identified as Viread 150 mg.
Viread is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 150 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 150 mg
- Prescription only
hypromellose 2910 (15000 mPa.s)
More about Viread (tenofovir)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.